Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review

Mounting evidence has shown that the risk of metabolic syndrome (MetS) is substantially overlapping in the diagnostic subgroups of psychiatric disorders. While it is widely acknowledged that patients receiving antipsychotic medications are at higher risk of MetS than antipsychotic-naive ones, the as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramaglia, Carla, Gambaro, Eleonora, Bartolomei, Giuseppe, Camera, Paolo, Chiarelli-Serra, Maira, Lorenzini, Luca, Zeppegno, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279880/
https://www.ncbi.nlm.nih.gov/pubmed/30546325
http://dx.doi.org/10.3389/fpsyt.2018.00621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279880/
https://www.ncbi.nlm.nih.gov/pubmed/30546325
http://dx.doi.org/10.3389/fpsyt.2018.00621

Ejemplares similares